« Back
Home /
HDAC8-IN-1

HDAC8-IN-1

Manufacturer	MedChem Express
Category	Oncology Neuroscience Neural Epigenetics Inhibitors & Compound Libraries Small Molecules By Organ Lung Cancer
Type	Inhibitors
Specific against	other
Amount	50 mg
Item no.	HY-111342-50mg
Targets	HDAC
CASRN	1417997-93-3
eClass 6.1	30220300
eClass 9.0	32160605
Available
Product Description	HDAC8-IN-1 is a HDAC8 inhibitor with an IC50 of 27.2 nM.
StorageTemperature	-20°C, 3 years; 4°C, 2 years (Powder)
Shipping	Room Temperature
Manufacturers Applications	Cancer-programmed cell death
MolecularWeight	345.39
Clinical_Information	No Development Reported
Manufacturers Research_Area	Cancer
Solubility	DMSO : 50 mg/mL (ultrasonic; warming; heat to 60°C)
Manufacturers Target	HDAC
Isoform	HDAC8
Pathway	Cell Cycle/DNA Damage; Epigenetics
Manufacturers Product type	Reference compound

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

HY-111342-50mg-safety-datasheet.pdf